BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/18/2023 7:44:15 AM | Browse: 448 | Download: 903
 |
Received |
|
2023-08-20 03:28 |
|
Peer-Review Started |
|
2023-08-20 03:28 |
|
First Decision by Editorial Office Director |
|
2023-09-29 02:47 |
|
Return for Revision |
|
2023-09-29 02:47 |
|
Revised |
|
2023-11-01 18:10 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2023-11-13 05:41 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2023-11-17 08:59 |
|
Articles in Press |
|
2023-11-17 08:59 |
|
Edit the Manuscript by Language Editor |
|
2023-11-10 05:46 |
|
Typeset the Manuscript |
|
2023-12-13 13:55 |
|
Publish the Manuscript Online |
|
2023-12-18 07:44 |
| ISSN |
2220-3230 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Transplantation |
| Manuscript Type |
Minireviews |
| Article Title |
Anti-thymocyte globulin for treatment of T-cell-mediated allograft rejection
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Sumit Acharya, Suraj Lama and Durga Anil Kanigicherla |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Suraj Lama, MBBS, MMed, PhD, Doctor, Doctor, Department of Nephrology, Shahid Dharmabhakta National Transplant Center, Dudhpati 1, Bhaktapur, Nepal, Bhaktapur 44800, Nepal. suraj_bhaju@yahoo.com |
| Key Words |
Anti-thymocyte globulin; T-cell-mediated rejection; Steroid-resistant rejection; Biopsy confirmed acute rejection |
| Core Tip |
Core Tip: Anti-thymocyte globulin is a highly efficient induction agent that can prevent acute rejection and delayed graft function. It is widely used for biopsy confirmed acute rejection reversal and steroid-resistant rejection. |
| Publish Date |
2023-12-18 07:44 |
| Citation |
Acharya S, Lama S, Kanigicherla DA. Anti-thymocyte globulin for treatment of T-cell-mediated allograft rejection. World J Transplant 2023; 13(6): 299-308 |
| URL |
https://www.wjgnet.com/2220-3230/full/v13/i6/299.htm |
| DOI |
https://dx.doi.org/10.5500/wjt.v13.i6.299 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
